Alyeska Investment Group’s Oculis Holding OCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-50,000
Closed -$598K 645
2024
Q2
$598K Buy
+50,000
New +$596K ﹤0.01% 493
2024
Q1
Sell
-50,000
Closed -$562K 569
2023
Q4
$562K Buy
+50,000
New +$519K ﹤0.01% 430
2023
Q3
Sell
-50,000
Closed -$617K 590
2023
Q2
$617K Buy
+50,000
New +$557K ﹤0.01% 482

Other funds holding OCS

Alyeska Investment Group's OCS Position: Q2 2026 in Review

Alyeska Investment Group reduced its Oculis Holding (OCS) stake by 38% in Q2 2026, selling an estimated $2.84M and leaving 206,332 shares worth $2.86M. The position accounts for 0.01% of the portfolio, ranked #549.

Alyeska Investment Group first reported a position in OCS in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.81M in Q1 2026. 59 funds tracked by Wall St. Rank hold OCS as of Q2 2026.

  • Alyeska Investment Group held 206,332 shares of Oculis Holding worth $2.86M as of Q2 2026.
  • Alyeska Investment Group sold 125,000 Oculis Holding shares in Q2 2026, an estimated $2.84M.
  • Oculis Holding made up 0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #549 holding.
  • Alyeska Investment Group first reported a position in Oculis Holding in Q1 2025 and has held it in 6 quarters since.
  • Alyeska Investment Group's Oculis Holding position peaked at $8.81M in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Oculis Holding as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.